NRXP

NASDAQStock

NRx Pharmaceuticals, Inc.

$1.82+0.03 (+1.39%)

52-Week Range

$1.68

$3.67

Key Stats

Market Cap

31.5M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.99

Volume

178.6K

Avg Volume

578.9K

Performance

-1.10%

-9.09%

-40.00%

YTD

-31.30%

-13.04%

-74.06%

-99.23%

Price Chart

ETF Exposure

NRXP is held by 4 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
PSIL	AdvisorShares Psychedelics ETF	3.30%	370,467	$682K	$20.4M	1.84%
IWC	iShares Micro-Cap ETF	0.01%	54,688	$99K	$1.27B	0.60%
VTI	Vanguard Total Stock Market ETF	0.00%	517,040	$1.1M	$2.10T	0.03%
VXF	Vanguard Extended Market ETF	0.00%	179,913	$378K	$84.10B	0.05%

About NRXP ETF Exposure

NRx Pharmaceuticals, Inc. (NRXP) is held by 4 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 31.5M, NRXP is a widely held institutional stock. The stock currently trades at $1.82. Investors can gain exposure to NRXP through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NRXP, sorted by portfolio weight.